These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the Quarterly Period Ended October 3, 2015 |
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
|
For the Transition Period from _____ to _____
|
|
Delaware
|
|
57-0426694
|
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
|
|
|
|
|
775 Spartan Blvd, Suite 102, P.O. Box 5627, Spartanburg, South Carolina
|
|
29304
|
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
(864) 585-3605
|
|
|
(Registrant's telephone number, including area code)
|
||
|
Large accelerated Filer
¨
|
Accelerated filer
x
|
Non-accelerated filer
¨
|
Smaller reporting company
¨
|
|
|
|
(Do not check if a smaller reporting company)
|
|
|
|
|
|
|
PART I
|
FINANCIAL INFORMATION
|
|
|
|
Item 1
.
|
Financial Statements
|
|
|
|
Condensed consolidated balance sheets - October 3, 2015 and January 3, 2015
|
|
|
|
Condensed consolidated statements of operations - Three and nine month periods ended October 3, 2015 and September 27, 2014
|
|
|
|
Condensed consolidated statements of cash flows - Nine months ended October 3, 2015 and September 27, 2014
|
|
|
|
Notes to condensed consolidated financial statements
|
|
|
Item 2.
|
Management's Discussion and Analysis of Financial Condition and Results of Operations
|
|
|
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk
|
|
|
Item 4.
|
Controls and Procedures
|
|
|
|
|
|
OTHER INFORMATION
|
||
|
|
Item 1.
|
Legal Proceedings
|
|
|
Item
1A.
|
Risk Factors
|
|
|
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds
|
|
|
Item 3.
|
Defaults Upon Senior Securities
|
|
|
Item 4.
|
Mine Safety Disclosures
|
|
|
Item 5.
|
Other Information
|
|
|
Item 6.
|
Exhibits
|
|
|
Signatures and Certifications
|
|
|
|
Oct 3, 2015
|
|
Jan 3, 2015
|
||||
|
|
(Unaudited)
|
|
|
||||
|
Assets
|
|
|
|
||||
|
Current assets
|
|
|
|
||||
|
Cash and cash equivalents
|
$
|
209,430
|
|
|
$
|
26,623
|
|
|
Accounts receivable, less allowance for doubtful accounts
|
|
|
|
||||
|
of $206,042 and $1,114,814, respectively
|
21,987,894
|
|
|
29,229,927
|
|
||
|
Inventories, net
|
67,963,222
|
|
|
67,674,670
|
|
||
|
Deferred income taxes
|
2,689,655
|
|
|
2,921,654
|
|
||
|
Prepaid expenses and other current assets
|
5,178,995
|
|
|
5,460,344
|
|
||
|
Total current assets
|
98,029,196
|
|
|
105,313,218
|
|
||
|
|
|
|
|
||||
|
Cash value of life insurance
|
1,524,360
|
|
|
2,046,512
|
|
||
|
Property, plant and equipment, net of accumulated
|
|
|
|
||||
|
depreciation of $49,379,609 and $46,036,102, respectively
|
43,348,323
|
|
|
39,937,466
|
|
||
|
Goodwill
|
18,512,979
|
|
|
23,250,201
|
|
||
|
Intangible asset, net of accumulated amortization
|
|
|
|
||||
|
of $5,147,250 and $3,455,475, respectively
|
15,309,750
|
|
|
17,001,525
|
|
||
|
Deferred charges, net and other non-current assets
|
443,238
|
|
|
300,308
|
|
||
|
Total assets
|
$
|
177,167,846
|
|
|
$
|
187,849,230
|
|
|
|
|
|
|
||||
|
Liabilities and Shareholders' Equity
|
|
|
|
||||
|
Current liabilities
|
|
|
|
||||
|
Accounts payable
|
$
|
11,072,264
|
|
|
$
|
21,388,298
|
|
|
Accrued expenses
|
8,339,199
|
|
|
14,684,686
|
|
||
|
Current portion of long-term debt
|
4,533,908
|
|
|
4,533,908
|
|
||
|
Other current liabilities
|
159,058
|
|
|
126,000
|
|
||
|
Total current liabilities
|
24,104,429
|
|
|
40,732,892
|
|
||
|
|
|
|
|
||||
|
Long-term debt
|
27,758,896
|
|
|
27,255,442
|
|
||
|
Long-term contingent consideration
|
—
|
|
|
2,596,516
|
|
||
|
Deferred income taxes
|
7,323,486
|
|
|
6,438,146
|
|
||
|
Long-term pension liability from the closure of Bristol Fab
|
—
|
|
|
713,181
|
|
||
|
Other long-term liabilities
|
661,000
|
|
|
659,500
|
|
||
|
|
|
|
|
||||
|
Shareholders' equity
|
|
|
|
||||
|
Common stock, par value $1 per share - authorized 12,000,000 shares; issued 10,300,000 shares
|
10,300,000
|
|
|
10,300,000
|
|
||
|
Capital in excess of par value
|
34,455,003
|
|
|
34,054,374
|
|
||
|
Retained earnings
|
86,615,537
|
|
|
79,167,323
|
|
||
|
|
131,370,540
|
|
|
123,521,697
|
|
||
|
Less cost of common stock in treasury: 1,587,662 and 1,589,698 shares, respectively
|
14,050,505
|
|
|
14,068,144
|
|
||
|
Total shareholders' equity
|
117,320,035
|
|
|
109,453,553
|
|
||
|
Commitments and contingencies – See Note 11
|
|
|
|
||||
|
Total liabilities and shareholders' equity
|
$
|
177,167,846
|
|
|
$
|
187,849,230
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
Oct 3, 2015
|
|
Sep 27, 2014
|
|
Oct 3, 2015
|
|
Sep 27, 2014
|
||||||||
|
Net sales
|
$
|
38,083,284
|
|
|
$
|
48,451,944
|
|
|
$
|
139,894,977
|
|
|
$
|
150,935,909
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Cost of sales
|
33,546,114
|
|
|
40,131,353
|
|
|
118,000,119
|
|
|
125,565,826
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Gross profit
|
4,537,170
|
|
|
8,320,591
|
|
|
21,894,858
|
|
|
25,370,083
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Selling, general and administrative expense
|
5,242,055
|
|
|
3,613,857
|
|
|
16,375,583
|
|
|
12,108,703
|
|
||||
|
Acquisition related costs
|
9,154
|
|
|
210
|
|
|
454,200
|
|
|
(2,936
|
)
|
||||
|
Business interruption insurance proceeds
|
(576,658
|
)
|
|
—
|
|
|
(1,056,775
|
)
|
|
—
|
|
||||
|
Operating (loss) income
|
(137,381
|
)
|
|
4,706,524
|
|
|
6,121,850
|
|
|
13,264,316
|
|
||||
|
Other (income) and expense
|
|
|
|
|
|
|
|
|
|
||||||
|
Interest expense
|
320,415
|
|
|
261,168
|
|
|
977,063
|
|
|
788,854
|
|
||||
|
Change in fair value of interest rate swap
|
247,152
|
|
|
(102,972
|
)
|
|
233,235
|
|
|
191,527
|
|
||||
|
Specialty and Palmer earn-out adjustments
|
(2,414,115
|
)
|
|
—
|
|
|
(4,897,448
|
)
|
|
(3,476,197
|
)
|
||||
|
Other, net
|
(23
|
)
|
|
(150
|
)
|
|
(137,214
|
)
|
|
(6,796
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Income from continuing operations before income taxes
|
1,709,190
|
|
|
4,548,478
|
|
|
9,946,214
|
|
|
15,766,928
|
|
||||
|
Provision for income taxes
|
354,000
|
|
|
1,371,000
|
|
|
2,498,000
|
|
|
4,557,000
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net income from continuing operations
|
1,355,190
|
|
|
3,177,478
|
|
|
7,448,214
|
|
|
11,209,928
|
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Loss from discontinued operations, net of tax
|
—
|
|
|
(1,898,988
|
)
|
|
—
|
|
|
(7,754,872
|
)
|
||||
|
|
|
|
|
|
|
|
|
||||||||
|
Net income
|
$
|
1,355,190
|
|
|
$
|
1,278,490
|
|
|
$
|
7,448,214
|
|
|
$
|
3,455,056
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per common share from continuing operations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.16
|
|
|
$
|
0.36
|
|
|
$
|
0.85
|
|
|
$
|
1.29
|
|
|
Diluted
|
$
|
0.16
|
|
|
$
|
0.36
|
|
|
$
|
0.85
|
|
|
$
|
1.29
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net loss per common share from discontinued operations:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
—
|
|
|
$
|
(0.22
|
)
|
|
$
|
—
|
|
|
$
|
(0.89
|
)
|
|
Diluted
|
$
|
—
|
|
|
$
|
(0.22
|
)
|
|
$
|
—
|
|
|
$
|
(0.89
|
)
|
|
|
|
|
|
|
|
|
|
||||||||
|
Net income per common share:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
$
|
0.16
|
|
|
$
|
0.14
|
|
|
$
|
0.85
|
|
|
$
|
0.40
|
|
|
Diluted
|
$
|
0.16
|
|
|
$
|
0.14
|
|
|
$
|
0.85
|
|
|
$
|
0.40
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
Weighted average shares outstanding:
|
|
|
|
|
|
|
|
||||||||
|
Basic
|
8,721,833
|
|
|
8,707,063
|
|
|
8,719,612
|
|
|
8,699,428
|
|
||||
|
Dilutive effect from stock options and grants
|
—
|
|
|
38,776
|
|
|
6,559
|
|
|
15,782
|
|
||||
|
Diluted
|
8,721,833
|
|
|
8,745,839
|
|
|
8,726,171
|
|
|
8,715,210
|
|
||||
|
|
Nine Months Ended
|
||||||
|
|
Oct 3, 2015
|
|
Sep 27, 2014
|
||||
|
Operating activities
|
|
|
|
||||
|
Net income
|
$
|
7,448,214
|
|
|
$
|
3,455,056
|
|
|
Loss from discontinued operations, net of tax
|
—
|
|
|
7,754,872
|
|
||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
|
||||
|
Depreciation expense
|
3,514,073
|
|
|
2,816,742
|
|
||
|
Amortization expense
|
1,771,265
|
|
|
1,027,105
|
|
||
|
Deferred income taxes
|
1,117,339
|
|
|
(631,624
|
)
|
||
|
Earn-out adjustments
|
(4,897,448
|
)
|
|
(3,476,197
|
)
|
||
|
(Reduction of) provision for losses on accounts receivable
|
(99,333
|
)
|
|
593,042
|
|
||
|
Provision for losses on inventory
|
1,632,000
|
|
|
3,828,122
|
|
||
|
Gain on sale of property, plant and equipment
|
(10,000
|
)
|
|
(8,000
|
)
|
||
|
Cash value of life insurance
|
64,000
|
|
|
(72,000
|
)
|
||
|
Change in fair value of interest rate swap
|
233,235
|
|
|
191,527
|
|
||
|
Environmental reserves
|
33,058
|
|
|
26,496
|
|
||
|
Issuance of treasury stock for director fees
|
118,762
|
|
|
110,501
|
|
||
|
Employee stock option and grant compensation
|
403,418
|
|
|
252,488
|
|
||
|
Changes in operating assets and liabilities:
|
|
|
|
|
|
||
|
Accounts receivable
|
7,341,366
|
|
|
(294,896
|
)
|
||
|
Inventories
|
397,635
|
|
|
(476,615
|
)
|
||
|
Other assets and liabilities, net
|
(881,765
|
)
|
|
305,948
|
|
||
|
Accounts payable
|
(10,316,034
|
)
|
|
2,656,999
|
|
||
|
Accrued expenses
|
(1,987,528
|
)
|
|
4,036,683
|
|
||
|
Accrued income taxes
|
739,590
|
|
|
(469,849
|
)
|
||
|
Net cash provided by continuing operating activities
|
6,621,847
|
|
|
21,626,400
|
|
||
|
Net cash (used in) provided by discontinued operating activities
|
(633,880
|
)
|
|
189,471
|
|
||
|
Net cash provided by operating activities
|
5,987,967
|
|
|
21,815,871
|
|
||
|
Investing activities
|
|
|
|
|
|
||
|
Purchases of property, plant and equipment
|
(7,439,218
|
)
|
|
(4,562,734
|
)
|
||
|
Proceeds from sale of property, plant and equipment
|
12,000
|
|
|
8,000
|
|
||
|
Proceeds from casualty insurance
|
512,287
|
|
|
—
|
|
||
|
Proceeds from life insurance
|
720,518
|
|
|
—
|
|
||
|
Net cash used in investing activities of continuing operations
|
(6,194,413
|
)
|
|
(4,554,734
|
)
|
||
|
Net cash provided by discontinued investing activities
|
—
|
|
|
3,586,044
|
|
||
|
Net cash used in investing activities
|
(6,194,413
|
)
|
|
(968,690
|
)
|
||
|
Financing activities
|
|
|
|
|
|
||
|
Net borrowings from line of credit
|
4,070,548
|
|
|
—
|
|
||
|
Payments on long-term debt
|
(3,567,094
|
)
|
|
(1,900,428
|
)
|
||
|
Proceeds from exercised stock options
|
8,302
|
|
|
27,026
|
|
||
|
Purchases of treasury stock
|
(122,503
|
)
|
|
—
|
|
||
|
Net cash provided by (used in) financing activities
|
389,253
|
|
|
(1,873,402
|
)
|
||
|
Increase in cash and cash equivalents
|
182,807
|
|
|
18,973,779
|
|
||
|
Cash and cash equivalents at beginning of period
|
26,623
|
|
|
1,773,743
|
|
||
|
Cash and cash equivalents at end of period
|
$
|
209,430
|
|
|
$
|
20,747,522
|
|
|
|
|
|
|
||||
|
Supplemental disclosure
|
|
|
|
||||
|
Cash paid during the year for:
|
|
|
|
||||
|
Interest
|
$
|
938,855
|
|
|
$
|
719,287
|
|
|
Income taxes
|
$
|
2,197,809
|
|
|
$
|
2,112,877
|
|
|
|
Oct 3, 2015
|
|
Jan 3, 2015
|
||||
|
Raw materials
|
$
|
38,697,581
|
|
|
$
|
38,405,587
|
|
|
Work-in-process
|
6,241,670
|
|
|
7,128,602
|
|
||
|
Finished goods
|
23,023,971
|
|
|
22,140,481
|
|
||
|
|
$
|
67,963,222
|
|
|
$
|
67,674,670
|
|
|
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
|
Oct 3, 2015
|
|
Sep 27, 2014
|
|
Oct 3, 2015
|
|
Sep 27, 2014
|
||||||||
|
Net sales
|
|
|
|
|
|
|
|
||||||||
|
Metals Segment
|
$
|
23,084,000
|
|
|
$
|
32,899,000
|
|
|
$
|
92,488,000
|
|
|
$
|
102,091,000
|
|
|
Specialty Chemicals Segment
|
14,999,000
|
|
|
15,553,000
|
|
|
47,407,000
|
|
|
48,845,000
|
|
||||
|
|
$
|
38,083,000
|
|
|
$
|
48,452,000
|
|
|
$
|
139,895,000
|
|
|
$
|
150,936,000
|
|
|
Operating (loss) income
|
|
|
|
|
|
|
|
|
|
||||||
|
Metals Segment
|
$
|
(548,000
|
)
|
|
$
|
3,840,000
|
|
|
$
|
5,400,000
|
|
|
$
|
11,000,000
|
|
|
Specialty Chemicals Segment
|
1,598,000
|
|
|
1,416,000
|
|
|
4,624,000
|
|
|
4,772,000
|
|
||||
|
|
1,050,000
|
|
|
5,256,000
|
|
|
10,024,000
|
|
|
15,772,000
|
|
||||
|
Unallocated expenses
|
|
|
|
|
|
|
|
||||||||
|
Corporate
|
1,179,000
|
|
|
549,000
|
|
|
3,448,000
|
|
|
2,510,000
|
|
||||
|
Acquisition related costs
|
9,000
|
|
|
—
|
|
|
454,000
|
|
|
(3,000
|
)
|
||||
|
Interest expense
|
320,000
|
|
|
261,000
|
|
|
977,000
|
|
|
789,000
|
|
||||
|
Change in fair value of interest rate swap
|
247,000
|
|
|
(103,000
|
)
|
|
233,000
|
|
|
192,000
|
|
||||
|
Palmer & Specialty earn-out adjustments
|
(2,414,000
|
)
|
|
—
|
|
|
(4,897,000
|
)
|
|
(3,476,000
|
)
|
||||
|
Other income
|
—
|
|
|
—
|
|
|
(137,000
|
)
|
|
(7,000
|
)
|
||||
|
Income from continuing operations
|
|
|
|
|
|
|
|
||||||||
|
before income taxes
|
$
|
1,709,000
|
|
|
$
|
4,549,000
|
|
|
$
|
9,946,000
|
|
|
$
|
15,767,000
|
|
|
|
|
|
|
|
|
|
|
||||||||
|
|
Oct 3, 2015
|
|
Jan 3, 2015
|
|
|
|
|
||||||||
|
Identifiable assets
|
|
|
|
|
|
|
|
||||||||
|
Metals Segment
|
$
|
135,196,000
|
|
|
$
|
145,558,000
|
|
|
|
|
|
||||
|
Specialty Chemicals Segment
|
33,792,000
|
|
|
32,504,000
|
|
|
|
|
|
||||||
|
Corporate
|
8,180,000
|
|
|
9,787,000
|
|
|
|
|
|
||||||
|
|
$
|
177,168,000
|
|
|
$
|
187,849,000
|
|
|
|
|
|
||||
|
|
|
Level 3 Liabilities
|
||
|
Balance at January 3, 2015
|
|
$
|
7,256,387
|
|
|
Interest expense charged during 2015
|
|
60,096
|
|
|
|
Reduction due to the finalization of Specialty's beginning balance sheet
|
|
(2,419,035
|
)
|
|
|
Change in fair value of Specialty's contingent consideration liability
|
|
(2,414,115
|
)
|
|
|
Change in fair value of Palmer's contingent consideration liability
|
|
(2,483,333
|
)
|
|
|
Balance at October 3, 2015
|
|
$
|
—
|
|
|
|
|
Three months ended
|
|
Nine months ended
|
||||
|
|
|
Sep 27, 2014
|
|
Sep 27, 2014
|
||||
|
Pro-forma revenues from continuing operations
|
|
$
|
56,683,000
|
|
|
$
|
175,221,000
|
|
|
Pro-forma net income from continuing operations
|
|
4,320,000
|
|
|
14,077,000
|
|
||
|
|
|
Three months ended
|
|
Nine months ended
|
|||||||
|
|
|
Sep 27, 2014
|
|
Sep 27, 2014
|
|||||||
|
|
|
|
|
|
|||||||
|
Net sales
|
|
$
|
3,252,000
|
|
|
$
|
21,963,000
|
|
|||
|
Loss before income taxes
|
|
$
|
(2,862,000
|
)
|
|
$
|
(11,299,000
|
)
|
|||
|
Benefit from income taxes
|
|
(963,000
|
)
|
|
(3,544,000
|
)
|
|||||
|
Net loss from discontinued operations
|
|
$
|
(1,899,000
|
)
|
|
$
|
(7,755,000
|
)
|
|||
|
Exhibit No.
|
|
Description
|
|
|
31.1
|
|
|
Rule 13a-14(a)/15d-14(a) Certifications of Chief Executive Officer
|
|
31.2
|
|
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer
|
|
31.3
|
|
|
Rule 13a-14(a)/15d-14(a) Certification of the Chief Accounting Officer
|
|
32
|
|
|
Certifications Pursuant to 18 U.S.C. Section 1350
|
|
101.INS*
|
|
|
XBRL Instance Document
|
|
101.SCH*
|
|
|
XBRL Taxonomy Extension Schema
|
|
101.CAL*
|
|
|
XBRL Taxonomy Extension Calculation Linkbase
|
|
101.LAB*
|
|
|
XBRL Taxonomy Extension Label Linkbase
|
|
101.PRE*
|
|
|
XBRL Taxonomy Extension Presentation Linkbase
|
|
101.DEF*
|
|
|
XBRL Taxonomy Extension Definition Linkbase
|
|
*
|
|
|
In accordance with Regulation S-T, the XBRL-related information in Exhibit 101 to this Quarterly Report on Form 10-Q shall be deemed "furnished" and not "filed."
|
|
|
|
|
|
SYNALLOY CORPORATION
|
||
|
(Registrant)
|
||
|
|
|
|
|
|
|
|
|
Date: November 12, 2015
|
By:
|
/s/ Craig C. Bram
|
|
|
|
Craig C. Bram
|
|
|
|
President and Chief Executive Officer
|
|
|
|
(principal executive officer)
|
|
|
|
|
|
Date: November 12, 2015
|
By:
|
/s/ Dennis M. Loughran
|
|
|
|
Dennis M. Loughran
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
|
|
(principal financial officer)
|
|
|
|
|
|
Date: November 12, 2015
|
By:
|
/s/ Richard D. Sieradzki
|
|
|
|
Richard D. Sieradzki
|
|
|
|
Vice President and Chief Accounting Officer
|
|
|
|
(principal accounting officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|